Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: Implications for the pathogenesis of tubulointerstitial fibrosis

Richard E. Gilbert, Leonard L. Wu, Darren J. Kelly, Alison Cox, Jennifer L. Wilkinson-Berka, Colin I. Johnston, Mark E. Cooper

Research output: Contribution to journalArticleResearchpeer-review

128 Citations (Scopus)


The finding that the systemic renin-angiotensin system (RAS) is not activated in most types of chronic renal disease has led to the suggestion that a local, intrarenal RAS may be an important determinant in the relentless progression of renal disease. Therefore, cell specific changes in various components of the RAS in response to renal mass reduction and angiotensin converting enzyme (ACE) inhibition were examined. Thirty Sprague- Dawley rats were randomly assigned to sham surgery, subtotal nephrectomy (STNx) alone or STNx treated with the ACE inhibitor, perindopril, and sacrificed after 12 weeks. In sham rats, renin mRNA and protein were only present in the juxtaglomerular apparatus. In contrast, in STNx kidneys, renin and angiotensin II expression were noted predominantly in renal tubular epithelial cells in association with overexpression of the prosclerotic cytokine, transforming growth factor-β1 (TGF-β1). In perindopril-treated STNx rats expression of renin and TGF-β1 were similar to control animals. These finding indicate that following renal mass reduction there is pathological tubular expression of various components of the RAS. Furthermore, in contrast to the juxtaglomerular apparatus, tubular renin expression was reduced with ACE inhibition. These changes within the intrarenal RAS may be pathogenetically linked to the development of tubulointerstitial injury.

Original languageEnglish
Pages (from-to)429-440
Number of pages12
JournalAmerican Journal of Pathology
Issue number2
Publication statusPublished - 1999
Externally publishedYes

Cite this